Vitruvian Shield completes an independent expert review through Instituto Pedro Nunes

Vitruvian Shield has completed an independent expert review by a clinical key opinion leader through Instituto Pedro Nunes, the Portuguese research and innovation institute, under the IPN healthproof Develop, Validate, Comply framework. The review was finalised on 28 May 2026 as a 14-page report, version Final v1.0, signed by an independent clinical expert whose identity is withheld in accordance with the report's anonymity provisions.

The review concludes that Vitruvian Shield is a clinically valuable and strategically promising platform for decentralised and hybrid clinical research, with a particularly credible initial pathway in oncology and a strong fit for academic centres and medium-sized research organisations. It is an expert opinion, not a study result.

The anonymised conclusion, methodology, SWOT and the ten recommendations with Vitruvian Shield's published response to each are on the independent expert review page in the Trust Portal.